THE Department of Human Services has released details of changes to PBS restrictions for growth hormone (GH) treatment in adults.
Effective 01 Jan, the aim is to provide more clarity and improved access to growth hormone treatment, following revised paediatric GH prescribing arrangements introduced last Feb.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jan 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jan 20
